Bombay Super Hybrid Seeds
- Market cap
- ₹ 870 Cr.
- P/E
- 30.5x
- P/B
- 7.06x
- 52-week range
- 59.16 – 125
- ROE
- 23%
- ROCE
- 16%
- Dividend yield
- 0%
- Debt / equity
- 0.83
- Sector
- Agricultural Food & other Products
- Industry
- Other Agricultural Products
- Listed on
- NSE, BSE
About
Bombay Super Hybrid Seeds Limited is an India-based company, which is engaged in the business of production, processing, and marketing of hybrid and GM Seeds. The Company has a product range of field crops and vegetable crops. The Company is in the business of production and processing of Agriculture Hybrid Seeds. The Company supplies seeds of grains and vegetables. Its products include Wheat, Maize, Bajra, Jowar, Gram, Soybean, Black Gram, Green Gram, Limabean, Pigeon Pea (Toor), Peas, Cowpea (Choli), Fenugreek, Groundnut, Sesame and Mustard. It serves various industries, such as food and beverages and agriculture. It offers seeds to farmers all across the country. It also offers Drumstick, Gum Guar, Lucerne, Rajka Bajri, Papaya, Watermelon, Muskmelon, Isabgol, Lentil, Hybrid Sweet Corn and other products. Its seeds are used to get nutritious wheat. The Company has a total of 85000 sq.ft ultra-modern seed processing unit at N H 8 B, Village: Kuchiyadad, Rajkot.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Other Agricultural Products: 90 companies →Bombay Super Hybrid Seeds against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)30.5 against a typical 14.5: pricier than most peers (1st = cheapest).62nd of 88
- Sales growth+219.8% against a typical +19.1% from a year earlier.4th of 68
- Profit growth+5.4% against a typical +5.4% from a year earlier.30th of 59
- Share price, 3 months−3.2% against a typical −4.1%.39th of 81
- Size₹ 869.9 Cr. market value against a typical ₹ 63 Cr. (1st = largest).12th of 85
Latest announcements
Exchange filings and their impact on the company.
- Strong H1 sales up 49% and Rs 85 cr debt cut overshadow flat Q2 profit.
Bombay Super Hybrid Seeds reported Q2 FY27 revenue of Rs 85.86 crore, up 220% from Rs 26.85 crore a year ago, with net profit of Rs 2.36 crore versus Rs 2.24 crore. For H1, revenue was Rs 268.43 crore versus Rs 179.79 crore and net profit Rs 16.66 crore versus Rs 14.51 crore. The half year also saw inventories fall by about Rs 130 crore, operating cash inflow of Rs 103.7 crore, and total borrowings cut from Rs 108.3 crore in March to Rs 23.1 crore in September while fixed assets expanded.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Look closer
Rated BBB+ by ICRA- CARE lowered its rating on 6 Oct 2026.
- The company stopped sharing information with CARE.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE BB+; ISSUER NOT COOPERATING* | Stable | 6 Oct 2026 |
| ICRA | [ICRA]BBB+ | Stable | 14 May 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 6 Oct 2026 | ▼ Downgrade | CARE BB+ | Low | CARE | ₹ 125 Cr. | |
| 14 May 2026 | New rating | [ICRA]BBB+ | — | ICRA | ₹ 145 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 10 Oct 2026 | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 7 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 25 May 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2026 and other business matters |
| 6 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 8 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 29 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 76 | 30 | 157 | 28 | 128 | 46 | 153 | 27 | 98 | 66 | 183 | 86 |
| Expenses | 67 | 27 | 143 | 25 | 118 | 40 | 138 | 23 | 88 | 60 | 165 | 82 |
| Operating Profit | 9 | 4 | 14 | 3 | 10 | 6 | 15 | 4 | 10 | 7 | 17 | 4 |
| OPM % | 12.1% | 11.7% | 8.7% | 11% | 7.8% | 13.4% | 10% | 15.5% | 9.8% | 9.8% | 9.4% | 5% |
| Other Income | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
| Interest | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Profit before tax | 8 | 3 | 12 | 2 | 9 | 5 | 13 | 2 | 9 | 4 | 15 | 3 |
| Tax % | 13.9% | −20.9% | 6.8% | 14.9% | 1.4% | 7.9% | 7% | 6.3% | 10.3% | −5.3% | 6.2% | 20.3% |
| Net Profit | 7 | 3 | 11 | 2 | 9 | 4 | 12 | 2 | 8 | 4 | 14 | 2 |
| EPS in Rs | 0.66 | 0.3 | 1.06 | 0.2 | 0.86 | 0.4 | 1.17 | 0.21 | 0.74 | 0.42 | 1.36 | 0.22 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 18%
- 5 Years
- 15%
- 3 Years
- 15%
- TTM
- 22%
- 10 Years
- 58%
- 5 Years
- 36%
- 3 Years
- 17%
- TTM
- 4%
- 10 Years
- —
- 5 Years
- 26%
- 3 Years
- −27%
- TTM
- —
- 10 Years
- 27%
- 5 Years
- 29%
- 3 Years
- 27%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Bombay Super Hybrid Seeds | ₹ 84.05 | ₹ 870 Cr. | 30.5x | 7.1x | 23% | — |
| Kaveri Seed Company | ₹ 731.00 | ₹ 3,752 Cr. | 14.8x | 2.5x | 18.2% | 21.2% |
| Andrew Yule & Company Ltd | ₹ 21.85 | ₹ 1,081 Cr. | — | 3.7x | −5.8% | −10.5% |
| Fratelli Vineyards | ₹ 123.50 | ₹ 537 Cr. | — | 3.2x | −17.1% | −13.7% |
| Harrisons Malayalam | ₹ 156.75 | ₹ 291 Cr. | 13.9x | 2.3x | 17.5% | 5.4% |
| Aelea Commodities | ₹ 129.60 | ₹ 264 Cr. | 14.2x | 2.4x | 18.7% | 5.6% |
Management
- Arvindkumar Jadavjibhai Kakadia
- Executive Chairman of the Board, Managing Director
- Kiritkumar Jadavjibhai Kakadia
- Chief Financial Officer, Whole Time Director
- Amitkumar D. Khandekar
- Company Secretary, Compliance Officer
- Hemang Chandrakant Baxi
- Executive Director
- Jadavjibhai Devrajbhai Kakadiya
- Executive Director
- Kishorkumar Devrajbhai Kakadiya
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.